Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 17,717 shares at $18.69 ($331K) on 2026-07-06, disclosed to the SEC on 2026-07-08.
Scheduled sale ($331k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $3.2M | — | Filing → |
| RLAY | SELL | 2026-05-14 | $228K | — | Filing → |